InvestorsHub Logo
Followers 34
Posts 3006
Boards Moderated 0
Alias Born 02/27/2016

Re: tredenwater2 post# 307486

Sunday, 04/18/2021 2:43:59 PM

Sunday, April 18, 2021 2:43:59 PM

Post# of 462576
True. Good thoughts.

But the patients down under have been on the OLE for quite sometime already and probably wouldn’t need someone like him just to crunch data. I’m guessing the trial sites continue to handle to OLE patients as well.

In regards to the new trials, they wouldn’t start until they’ve received a blessing from a regulatory body and we probably would have heard that material info already. I guess he could be getting things ready.

Although that job doesn’t seem like a promotion. The only way he would leave his current position would be a promotion or a pay raise with of course options like some have said. I’m sure he was making pretty good money after more than 4 years at Hammond.

I think we will find out soon. Whatever it is, it’s a good sign of things working behind the scenes while we wait.

I’m wondering if his position is a prerequisite for getting some favorable expedited path. We definitely qualify as seen by the research done on this board.

I’m also wondering if the government can take it upon themselves to look at the Alz data independently. That would bypass any negative effects of a sneak peak by the company.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News